. . . . . . . . . . "a(SCHEM:fibrate) -| path(SDIS:\"Atherosclerotic lesion\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Conversely, antidiabetic glitazones and hypolipidemic fibrate drugs, known as PPARgamma and PPARalpha ligands, respectively, reduce the process of atherosclerotic lesion formation" . . "Selventa" . . . . "2014-07-03T14:30:01.255+02:00"^^ . . .